Invention Grant
- Patent Title: Tumour-associated peptides that bind to MHC molecules
-
Application No.: US12632463Application Date: 2010-01-22
-
Publication No.: US08399613B2Publication Date: 2013-03-19
- Inventor: Toni Weinschenk , Hans Georg Rammensee , Stefan Stevanovic
- Applicant: Toni Weinschenk , Hans Georg Rammensee , Stefan Stevanovic
- Applicant Address: DE Tubingen
- Assignee: Immatics Biotechnologies GmbH
- Current Assignee: Immatics Biotechnologies GmbH
- Current Assignee Address: DE Tubingen
- Agency: Baker Donelson Bearman, Caldwell & Berkowitz, PC
- Priority: DE10225144 20020529
- Main IPC: C07K7/06
- IPC: C07K7/06
Abstract:
The invention relates to a tumor-associated peptide containing an amino sequence, which is selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:79 of the enclosed listing. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I. The invention also relates to the use of the peptides for manufacture of a medicament and for treating tumorous diseases. The invention further relates to a pharmaceutical composition, which comprises at least one of the peptides.
Public/Granted literature
- US20100184211A1 Tumour-Associated Peptides that Bind to MHC Molecules Public/Granted day:2010-07-22
Information query
